X0206 3 2023-08-10 0 0001826667 TriSalus Life Sciences, Inc. TLSI 0001410289 Szela Mary T 6272 W. 91ST AVENUE WESTMINSTER CO 80031 1 1 0 0 CEO and President Common Stock 279963 D Employee Stock Option (right to buy) 1.22 2028-01-29 Common Stock 177973 D Employee Stock Option (right to buy) 0.41 2030-10-05 Common Stock 17302 D Employee Stock Option (right to buy) 0.41 2031-04-20 Common Stock 101345 D Employee Stock Option (right to buy) 2.43 2031-11-02 Common Stock 216287 D Employee Stock Option (right to buy) 2.43 2032-04-19 Common Stock 55616 D Employee Stock Option (right to buy) 10.30 2033-05-18 Common Stock 58409 D The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director and an executive officer of the Issuer. The Reporting Person was appointed as a director and an executive officer of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.). Includes 36,774 shares issued pursuant to a restricted stock unit award ("RSU"). The RSU vests in four equal annual installments commencing on October 5, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. The shares subject to this stock option became fully vested on January 22, 2022. The shares subject to this stock option vest in 48 equal monthly installments from the vesting commencement date of October 1, 2020, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Twenty-five percent of the shares subject to the option vested on November 3, 2022, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Seventy-five percent of the shares subject to this stock option vests on April 20, 2025, the third anniversary of the vesting commencement date, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Twenty-five percent of the shares subject to the option vests on May 19, 2024, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. /s/ Mary Szela 2023-08-14